Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) Shareholder News: Investigation over Potential Wrongdoing
An investigation was announced for investors in shares of Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) was announced over potential breaches of fiduciary duties by certain directors at Oramed Pharmaceuticals.
View full press release